139 related articles for article (PubMed ID: 10232930)
21. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
Kukanich B; Papich MG
J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of D(+)-usnic acid in rabbits after intravenous and oral administration.
Krishna DR; Venkataramana D
Drug Metab Dispos; 1992; 20(6):909-11. PubMed ID: 1362945
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of the anti-leishmanian agent WR 6026 in dogs.
Taylor T; Hawkins DR; Morris GR; Chung H
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():136-9. PubMed ID: 1820868
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of N-nitrosodimethylamine in beagles.
Gombar CT; Pylypiw HM; Harrington GW
Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
[TBL] [Abstract][Full Text] [Related]
26. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
27. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig.
Goyarts T; Dänicke S
Toxicol Lett; 2006 Jun; 163(3):171-82. PubMed ID: 16326049
[TBL] [Abstract][Full Text] [Related]
29. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
30. [The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs].
Hashem A; Kietzmann M; Scherkl R
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):396-8. PubMed ID: 1425314
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
32. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
Shilo Y; Britzi M; Eytan B; Lifschitz T; Soback S; Steinman A
J Vet Pharmacol Ther; 2008 Feb; 31(1):60-5. PubMed ID: 18177320
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and bioavailability of spectinomycin after i.v., i.m., s.c. and oral administration in broiler chickens.
Abu-Basha EA; Gehring R; Albwa'neh SJ
J Vet Pharmacol Ther; 2007 Apr; 30(2):139-44. PubMed ID: 17348899
[TBL] [Abstract][Full Text] [Related]
35. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
Batzias GC; Delis GA; Athanasiou LV
Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats.
Pypendop BH; Ilkiw JE
J Vet Pharmacol Ther; 2008 Feb; 31(1):52-9. PubMed ID: 18177319
[TBL] [Abstract][Full Text] [Related]
38. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of cannabidiol in dogs.
Samara E; Bialer M; Mechoulam R
Drug Metab Dispos; 1988; 16(3):469-72. PubMed ID: 2900742
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of fosfosal in rats and dogs.
Ramis J; Mis R; Forn J
Arzneimittelforschung; 1989 Jan; 39(1):74-7. PubMed ID: 2719746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
